Fertin Pharma’s Parent Company Acquires MedCan Pharma – Allowing Entry into Fast-growing Market for Cannabinoid Products

VEJLE, Denmark, Jan. 7 (Korea Bizwire) — Claudio Bidco A/S (the “Parent Company”), the parent company of Fertin Pharma A/S (“Fertin Pharma”) has signed and closed the acquisition of MedCan Pharma A/S (“MedCan Pharma”), a research organisation focusing on developing innovative products containing cannabinoids with a primary focus on the fast-growing market for medicated cannabis. [...]